{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=GLUT1DS1", "query": { "condition": "GLUT1DS1" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 6, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T05:34:31.317Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05085704", "title": "Brain Metabolism Observed at 7 Tesla", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Glut1 Deficiency Syndrome 1", "Glucose Metabolism Disorders", "Epilepsy", "Glut1 Deficiency Syndrome 1, Autosomal Recessive", "Glucose Transporter Type 1 Deficiency Syndrome", "Glucose Transporter Protein Type 1 Deficiency Syndrome", "Glucose Transport Defect" ], "interventions": [ { "name": "Magnetic resonance imaging", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "16 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2022-05-03", "completion_date": "2026-09-20", "has_results": false, "last_update_posted_date": "2023-10-25", "last_synced_at": "2026-05-22T05:34:31.317Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05085704" }, { "nct_id": "NCT03181399", "title": "Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "GLUT1DS1", "Epilepsy", "Glut1 Deficiency Syndrome 1, Autosomal Recessive", "Glucose Metabolism Disorders", "Glucose Transport Defect", "Glucose Transporter Type 1 Deficiency Syndrome", "Glucose Transporter Protein Type 1 Deficiency Syndrome" ], "interventions": [ { "name": "Triheptanoin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "24 Months", "maximum_age": "35 Years", "sex": "ALL", "summary": "24 Months to 35 Years" }, "enrollment_count": 45, "start_date": "2018-04-18", "completion_date": "2023-09-10", "has_results": true, "last_update_posted_date": "2025-08-07", "last_synced_at": "2026-05-22T05:34:31.317Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03181399" }, { "nct_id": "NCT03041363", "title": "Treatment Development of Triheptanoin (G1D)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Epilepsy", "GLUT1DS1", "Glut1 Deficiency Syndrome 1, Autosomal Recessive", "Glucose Metabolism Disorders", "Glucose Transport Defect", "Glucose Transporter Type 1 Deficiency Syndrome", "Glucose Transporter Protein Type 1 Deficiency Syndrome" ], "interventions": [ { "name": "Triheptanoin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Juan Pascual", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "2 Years to 35 Years" }, "enrollment_count": 12, "start_date": "2017-03-29", "completion_date": "2017-12-22", "has_results": false, "last_update_posted_date": "2022-12-22", "last_synced_at": "2026-05-22T05:34:31.317Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03041363" }, { "nct_id": "NCT03301532", "title": "Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "GLUT1DS1" ], "interventions": [ { "name": "Triheptanoin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Months", "maximum_age": "35 Years", "sex": "ALL", "summary": "30 Months to 35 Years" }, "enrollment_count": 10, "start_date": "2018-06-05", "completion_date": "2022-07-31", "has_results": true, "last_update_posted_date": "2024-01-17", "last_synced_at": "2026-05-22T05:34:31.317Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03301532" }, { "nct_id": "NCT07432490", "title": "A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glut1 Deficiency", "GLUT1DS1" ], "interventions": [ { "name": "L-fucose", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Oregon Health and Science University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2026-05-05", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-05-22T05:34:31.317Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT07432490" }, { "nct_id": "NCT04137692", "title": "Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Glucose Transporter Type 1 Deficiency Syndrome", "GLUT1DS1" ], "interventions": [ { "name": "Red Blood Cell Transfusion", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 12, "start_date": "2027-09", "completion_date": "2031-08", "has_results": false, "last_update_posted_date": "2025-12-11", "last_synced_at": "2026-05-22T05:34:31.317Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04137692" } ] }